Publicaciones en las que colabora con Miguel Ángel Gómez Bravo (4)

2022

  1. miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma

    Cells, Vol. 11, Núm. 17

2018

  1. Incidence and survival rate of de novo tumors in liver transplants

    Cirugia Espanola, Vol. 96, Núm. 8, pp. 501-507

  2. Translational pancreatic cancer research: A comparative study on patient-derived xenograft models

    World Journal of Gastroenterology, Vol. 24, Núm. 7, pp. 794-809

2011

  1. Choice of calcineurin inhibitor may influence the development of de novo immune hepatitis associated with anti-GSTT1 antibodies after liver transplantation

    Clinical Transplantation, Vol. 25, Núm. 2, pp. 207-212